PATENT CLAIM ANALYSIS

Application Number: 15885197
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "204100"]

Abstract:
Embodiments of the disclosure concern methods and compositions for immunotherapy for human papillomavirus infection and diseases associated therewith. In specific embodiments, methods concern production of immune cells that target one or more antigens of HPV16 and/or HPV18, including methods with stimulation steps that employ IL-7 and IL-15, but not IL-6 and/or IL-12. Other specific embodiments utilize stimulations in the presence of certain cells, such as costimulatory cells and certain antigen presenting cells.

Claim (Index 5):
The method according to  claim 3 , wherein the DCs are derived from CD14+ cells by a method comprising culturing the CD14+ cells in the presence of IL-4 and GM-CSF to produce immature DCs (iDCs).

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.43636
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15331659', '14453286', '14364592', '15678970', '12451983']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7217695617011918
- 35 USC 102 Novelty (BERT): 0.5638916574255717
- Combined Prediction Score: 0.7059817712736297
- Mean Citation Score: 355.407312
- Max Citation Score: 460.05124000000006
- Similarity Product: 325.79281243767736

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test